Detalhe da pesquisa
1.
A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma.
Cancer Immunol Immunother
; 72(7): 2267-2282, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881133
2.
Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonist.
Org Biomol Chem
; 17(5): 1225-1237, 2019 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30656346
3.
Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variants.
iScience
; 26(4): 106256, 2023 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36845030
4.
Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy.
Front Immunol
; 12: 748741, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34737749
5.
NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity.
Chem Sci
; 6(9): 5120-5127, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28717498